Non-interference Study of MR and Yellow Fever Vaccines Among Bangladeshi Infants Aged 9-12 Months

计划入组 1,530 人 · 首次发布于 2025 年 2 月 7 日

Edwards Lifesciences Self-Expanding Stent Peripheral Vascular Disease Study

计划入组 246 人 · 首次发布于 2008 年 5 月 7 日

Clinical Outcomes of Edwards Lifesciences MITRIS RESLILA Mitral Valve in the Asian Population

计划入组 200 人 · 首次发布于 2025 年 1 月 3 日

Pertuzumab Biosimilar (Zydus Lifesciences Ltd.)

Sitagliptin/Metformin Hydrochloride (Zydus Lifesciences)

Peginterferon alpha-2b biosimilar(Zydus Lifesciences)

Zydus Lifesciences Ltd.

India

Zydus Lifesciences Limited

India

ZYDUS LIFESCIENCES GLOBAL FZE

United Arab Emirates

Zydus Amplitude's Robotic Surgical System 'Andy' Receives CE Mark Approval for European Market

Zydus Lifesciences Receives FDA Approval for Generic Celecoxib Capsules in Multiple Strengths

Zydus Lifesciences Secures First Drug Approval in China for Venlafaxine ER Capsules